Purchase Order FA520922P0149
Award Date 8/19/22
Potential Completion Date 3/11/23
Potential Value $80K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South Korea
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order contract, valued at $99,936.68, was awarded by the U.S. Army Materiel Command Research, Development and Engineering Command (RDECOM) to the Gwangju Institute of Science and Technology (GIST), a foreign government entity based in South Korea. The contract is for the development of a colorimetric biosensing smart skin for the Army Research & Development - International Center Indo-Pacific (ITC-IPAC) program. The work is being performed in South Korea and is...
- This is a $240,000.00 firm fixed price contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Intralytix Inc., a for-profit biotech organization that specializes in bacteriophage-based products for food safety and public health applications. The contract, which does not have a set-aside designation, is for the "Elucidation of Interaction of Bacteriophages with Bacteria in Various Food Matrixes, and the Impact on the Food...
- This is a $1,430,615.73 firm fixed-price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES" and has an ultimate completion date of October 15, 2020. The contract was awarded on February 19, 2018 and is designated as a...
- <p>This is a $1,149,992.71 firm-fixed-price Definitive Contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Phosphortech Corporation, a small business, for services related to the Small Business Technology Transfer (STTR) program. The contract has a period of performance through March 29, 2021 and is designated as a Total Small Business set-aside. The contract is for STTR Phase I research and development efforts.</p>
- This contract award to Namu Med Sales Division, a for-profit company, provides biochemical antibiotics susceptibility testing reagents and supplies to support medical facilities and research programs operated by the U.S. Department of the Army Medical Command in South Korea. The $114,863.19 firm fixed price delivery order is part of a larger indefinite delivery contract (IDC) vehicle managed by the Defense Health Agency (DHA) and Department of the Army Medical Command. The contract has no...
- This is a firm fixed-price purchase order awarded by the Department of the Army Medical Command to Specific Diagnostics, Inc., a for-profit small business, under the Small Business Innovation Research (SBIR) program. The contract is for medical research and development titled "Rapid Bacteriophage Susceptibility Testing Using Small Molecule Sensor Technology" and has a potential value of $248,845.27. The contract was awarded on March 2, 2021, with an expected completion date of...
- This is a $299,999.66 firm-fixed-price delivery order contract awarded by the Defense Health Agency (DHA) to Eitr Biologics, Inc., a for-profit biotechnology company. The contract is for the development of novel nanotherapeutics to combat viral infections and other biological threats, with a performance period through June 2026. Eitr Biologics has previously received multiple federal contract awards and grants from agencies like the Centers for Disease Control and Prevention (CDC) and the...
- The Department of the Army awarded a $53,334 fixed price purchase order to Bio-Active Company LIMITED to acquire Illumina reagents in support of the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand. Under this contract, Bio-Active will deliver the requested genetic sequencing materials to AFRIMS between September and November 2023 to support the Institute's biomedical research efforts. No subcontractors or set aside designations were identified. The Army...
- This is a $148,129.23 firm-fixed-price definitive contract awarded to Foundation For Science Innovation And Development, a foreign-owned non-profit research organization based in Bengaluru, India. The contract is for fundamental research on an "Information Theoretic View of Turbulence Physics and Dynamics" in support of the U.S. Army Combat Capabilities Development Command (DEVCOM) Indo-Pacific's Broad Agency Announcement (BAA) focused on scientific and technological research in the...
- This firm fixed price delivery order contract was awarded by the Defense Health Agency to Namu Med's Sales Division, a for-profit corporate entity, to provide reagents for biochemical antibiotics susceptibility testing and related supplies to support medical facilities and research programs operated by the Department of the Army Medical Command in South Korea. The contract has a potential value of $50,000.00 and a completion date of September 30, 2023. It is not set aside for a specific business...
This is a $80,000.00 firm fixed-price purchase order awarded by the U.S. Army Research, Development and Engineering Command (DEVCOM) to Intron Biotechnology, Inc., a for-profit organization based in South Korea. The contract is for "ARMY RESEARCH AND DEVELOPMENT-INTERNATIONAL TECHNOLOGY CENTER INDO-PACIFIC (ITC-IPAC), UPEC TARGETING PHAGE ANTIMICROBIALS" and has a period of performance ending on March 11, 2023. The contract is not designated as a set-aside. Based on the agency and the description, this award appears to be part of DEVCOM's research and development efforts focused on antimicrobial technologies, likely with applications in the Indo-Pacific region.
Generated 4/2/25, 8:57 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $80.0k | 8/19/22 |